Predicting Breast Flap Necrosis by Spatial Frequency Domain Imaging
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02273076|
Recruitment Status : Withdrawn
First Posted : October 23, 2014
Last Update Posted : August 30, 2017
The current surgical procedure for breast diseases places an emphasis on the conservation of breast skin in order to provide more optimal reconstruction.
The purpose of this study is to use portable, non-contact optical imaging device developed at the Beckman Laser Institute called Spatial Frequency Domain Imaging to detect the changes in a skin during reconstructive surgery procedure and healing process.
|Condition or disease||Intervention/treatment|
|Disorders of Skin Grafts and Flaps||Device: Spatial Frequency Domain Imaging|
The researchers can use Spatial Frequency Domain Imaging instrument to measure the concentration of blood flow in the skin tissue and can determine of the changes that observed in the properties of the mastectomy flap that may be delay in healing process.
The imaging device can determine the change from baseline measurement to the development of skin necrosis, wound infection, or implant extrusion.
|Study Type :||Observational|
|Actual Enrollment :||0 participants|
|Official Title:||Predicting Breast Flap Necrosis by Spatial Frequency Domain Imaging|
|Study Start Date :||October 2014|
|Estimated Primary Completion Date :||October 2019|
|Estimated Study Completion Date :||October 2019|
- Device: Spatial Frequency Domain Imaging
Spatial Frequency Domain Imaging
- skin flap healing [ Time Frame: up to 6 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02273076
|United States, California|
|Orange, California, United States, 92697|
|Principal Investigator:||Gregory Evans, MD||UCIMC|